Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/8586
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Budiarti, Retno | - |
dc.contributor.author | Ediono, Ediono | - |
dc.contributor.author | Miftahussurur, Muhammad | - |
dc.date.accessioned | 2024-11-29T03:49:14Z | - |
dc.date.available | 2024-11-29T03:49:14Z | - |
dc.date.issued | 2024 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/8586 | - |
dc.description.abstract | Objective: This study aimed to compare the most useful biomarkers for predicting prognosis and response to therapy in COVID-19 patients. Material and Methods: This quantitative study involved 639 patients who were hospitalized with COVID-19 infection. Patients without any biochemical marker result; patients referred to another hospital; and peripheral oxygen levels measured using oxygen supplementation were excluded from the study. Results: There was a statistically significant difference in terms of demographics, vital signs on admission, and laboratory parameters. The risk of mortality in COVID-19 is significantly influenced by c-reactive protein (CRP) and interleukin-6 (IL-6) levels (p-value <0.05). Conclusion: Findings revealed these biomarkers could help the future development of more personalized treatment and diagnostic approaches. Keywords: Biomarker, COVID-19, Outcome. | en_US |
dc.subject | Biomarker, COVID-19, Outcome. | en_US |
dc.title | Biomarker Profiles Associated with Covid-19 Mortality in East Java, Indonesia: A Tertiary Care Hospital Study | en_US |
dc.type | Article | en_US |
Appears in Collections: | VOL 16 NO 3 2024 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.